Literature DB >> 11378328

Interleukin-8-positive neutrophils in psoriasis.

H Duan1, T Koga, F Kohda, H Hara, K Urabe, M Furue.   

Abstract

We performed an immunohistochemical study to try to determine the cellular source of interleukin-8 (IL-8) in psoriatic skin lesions. IL-8 was positively stained in the vast majority of neutrophils but not in the mononuclear cells, macrophages, or keratinocytes. IL-8-positive neutrophils were seen both in Munro's microabcesses in cases of psoriasis vulgaris and in a small spongiform pustule and much larger macropustules of Kogoj in cases of pustular psoriasis. Some IL-8-positive neutrophils were observed in the upper dermis of pustular psoriasis. The staining was considered to be specific because it could be completely blocked by preabsorption with recombinant IL-8. In addition, stimulation of human neutrophils with lipopolysaccharide (LPS) or tumor necrosis factor-alpha (TNF-alpha) for 18 h induced IL-8 production in vitro. In our study, IL-8 was expressed in the neutrophils of psoriasis, suggesting that neutrophils are one of the sources of IL-8 in psoriasis. The expression of IL-8 and the influx of neutrophils led us to speculate that the IL-8 autocrine and/or paracrine system functions in the formation of the microabcesses and pustules in proriasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378328     DOI: 10.1016/s0923-1811(00)00167-5

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  16 in total

Review 1.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 2.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

3.  Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.

Authors:  Marie Fischer; Ilkka T Harvima; Ricardo F S Carvalho; Christine Möller; Anita Naukkarinen; Gunilla Enblad; Gunnar Nilsson
Journal:  J Clin Invest       Date:  2006-09-07       Impact factor: 14.808

4.  Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.

Authors:  Emiliano Antiga; Walter Volpi; Elisa Cardilicchia; Laura Maggi; Lucia Filì; Cinzia Manuelli; Paola Parronchi; Paolo Fabbri; Marzia Caproni
Journal:  J Clin Immunol       Date:  2012-06-15       Impact factor: 8.317

5.  Integrated metabolomic analysis and cytokine profiling define clusters of immuno-metabolic correlation in new-onset psoriasis.

Authors:  Elisabetta Tarentini; Giulia Odorici; Valeria Righi; Alessia Paganelli; Luca Giacomelli; Valentina Mirisola; Adele Mucci; Luisa Benassi; Elisabetta D'Aversa; Claudia Lasagni; Shaniko Kaleci; Eva Reali; Cristina Magnoni
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

6.  Immunohistochemical Comparison of IL-36 and the IL-23/Th17 Axis of Generalized Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis.

Authors:  Hyo Sang Song; Sang Jin Kim; Tae-In Park; Yong Hyun Jang; Eun-So Lee
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

7.  Increased IL17A, IFNG, and FOXP3 Transcripts in Moderate-Severe Psoriasis: A Major Influence Exerted by IL17A in Disease Severity.

Authors:  Priscilla Stela Santana de Oliveira; Michelly Cristiny Pereira; Simão Kalebe Silva de Paula; Emerson Vasconcelos Andrade Lima; Mariana Modesto de Andrade Lima; Rodrigo Gomes de Arruda; Wagner Luís Mendes de Oliveira; Ângela Luzia Branco Pinto Duarte; Ivan da Rocha Pitta; Moacyr Jesus Melo Barreto Rêgo; Maira Galdino da Rocha Pitta
Journal:  Mediators Inflamm       Date:  2016-11-30       Impact factor: 4.711

Review 8.  The IL-23/IL-17 axis in psoriatic arthritis.

Authors:  Erika Suzuki; Elizabeth D Mellins; M Eric Gershwin; Frank O Nestle; Iannis E Adamopoulos
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

9.  Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils.

Authors:  Patrice E Poubelle; Arpita Chakravarti; Maria J Fernandes; Karine Doiron; Andrée-Anne Marceau
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  A systematic review on the efficacy and safety of Infliximab in patients with psoriasis.

Authors:  Jin Wang; Qingxia Zhan; Litao Zhang
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.